New diorganotin(IV) derivatives of 7-hydroxycoumarin (umbelliferone) and their adducts with 1,10-phenanthroline

被引:7
|
作者
Nath, M [1 ]
Jairath, R
Eng, G
Song, XQ
Kumar, A
机构
[1] Indian Inst Technol, Dept Chem, Roorkee 247667, Uttar Pradesh, India
[2] Univ Dist Columbia, Dept Chem & Phys, Washington, DC 20008 USA
[3] LLRM Med Coll, Dept Pharmacol, Meerut 25004, Uttar Pradesh, India
关键词
diorganotin(IV); umbelliferone; 7-hydroxycoumarin; 1,10-phenanthroline; Sn-119; Mossbauer; NMR;
D O I
10.1016/j.saa.2004.11.050
中图分类号
O433 [光谱学];
学科分类号
0703 ; 070302 ;
摘要
New diorganotin(IV) derivatives of the general formula R2Sn(Umb)(2) (where R = n-Bu, n-Oct and Ph; Umb = umbelliferone anion) have been synthesized either by the reaction of R2SnO with umbelliferone under azeotropic removel of water or by the reaction of R2SnCl2 with sodium salt of umbelliferone. Further, the adducts of the general formula R2Sn(Umb)2.phen (where R = n-Bu and n-Oct; phen = 1, 10-phenanthroline) have also been synthesized by the interaction of R2Sn(Umb)2 with 1,10-phenanthroline. The bonding and coordination behavior in these derivatives are discussed on the basis of IR and Sn-119 Mossbauer spectroscopic studies in solid state. Their coordination behavior in solution is discussed by the multinuclear (H-1, C-13 and Sn-119) NMR spectral studies. The Mossbauer and IR studies indicate that umbelliferone acts as a monoanionic bidentate ligand in R2Sn(Umb)(2) coordinating through O(7) and O(1). A distorted octahedral geometry around tin has been proposed for R2Sn(Umb)(2) as well as for R2Sn(Umb)(2)center dot phen in solid state. The newly synthesized derivatives have been tested for their anti-inflammatory and cardiovascular activities. The average LD50 value > 1000 mg kg(-1) of these compounds indicates their safety margin. (c) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:3155 / 3161
页数:7
相关论文
共 50 条
  • [21] 1,10-Phenanthroline derivatives as mediators for glucose oxidase
    Oztekin, Yasemin
    Krikstolaityte, Vida
    Ramanaviciene, Almira
    Yazicigil, Zafer
    Ramanavicius, Arunas
    BIOSENSORS & BIOELECTRONICS, 2010, 26 (01): : 267 - 270
  • [22] A COLORIMETRIC STUDY OF 2 DERIVATIVES OF 1,10-PHENANTHROLINE
    HALE, MN
    MELLON, MG
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1950, 72 (07) : 3217 - 3220
  • [23] SYNTHESIS AND FUNCTIONS OF 1,10-PHENANTHROLINE DERIVATIVES AS IONOPHORES
    SUGIHARA, H
    HIRATANI, K
    JOURNAL OF SYNTHETIC ORGANIC CHEMISTRY JAPAN, 1994, 52 (06) : 530 - 538
  • [24] METAL-COMPLEXES OF 1,10-PHENANTHROLINE DERIVATIVES .7. COMPLEXES OF 1,10-PHENANTHROLINE-2-CARBALDEHYDE HYDRAZONES
    GOODWIN, HA
    MATHER, DW
    AUSTRALIAN JOURNAL OF CHEMISTRY, 1974, 27 (05) : 965 - 972
  • [25] Cytotoxicity and effects of 1,10-phenanthroline and 5-amino-1,10-phenanthroline derivatives on some immunocompetent cells
    Wesselinova, Diana
    Kaloyanov, Nikolay
    Dimitrov, Georgi
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2009, 44 (12) : 5099 - 5102
  • [26] A new approach to the 1,10-phenanthroline core
    Chelucci, Giorgio
    Addis, Daniele
    Baldino, Salvatore
    TETRAHEDRON LETTERS, 2007, 48 (19) : 3359 - 3362
  • [27] Synthesis and anti-cholinesterase activity of new 7-hydroxycoumarin derivatives
    Alipour, Masoumeh
    Khoobi, Mehdi
    Moradi, Alireza
    Nadri, Hamid
    Moghadam, Farshad Homayouni
    Emami, Saeed
    Hasanpour, Zeinab
    Foroumadi, Alireza
    Shafiee, Abbas
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2014, 82 : 536 - 544
  • [28] TETRAKIS-(1,10-PHENANTHROLINE)CERIUM(IV) NITRATE
    BREZINA, F
    ZEITSCHRIFT FUR CHEMIE, 1973, 13 (10): : 383 - 383
  • [29] Dimeric Oxidovanadium(IV) Complex Bearing 1,10-Phenanthroline
    I. Charamzová
    J. Honzíček
    P. Kalenda
    J. Vinklárek
    I. Císařová
    Crystallography Reports, 2020, 65 : 1129 - 1132
  • [30] Dimeric Oxidovanadium(IV) Complex Bearing 1,10-Phenanthroline
    Charamzova, I.
    Honzicek, J.
    Kalenda, P.
    Vinklarek, J.
    Cisarova, I.
    CRYSTALLOGRAPHY REPORTS, 2020, 65 (07) : 1129 - 1132